Compounds > 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one
Page last updated: 2024-08-26

7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one and naltrexone

7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one has been researched along with naltrexone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beinborn, M; Carr, DB; Foran, SE; Kopin, AS; Kream, RM; Lipkowski, AW; Marchand, JE; Maszczynska, I; Misicka, A1

Other Studies

1 other study(ies) available for 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one and naltrexone

ArticleYear
Inhibition of morphine tolerance development by a substance P-opioid peptide chimera.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 295, Issue:3

    Topics: Analgesics, Opioid; Animals; Drug Tolerance; Indoles; Isoindoles; Male; Morphine; Naltrexone; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Structure-Activity Relationship; Substance P

2000